{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:46:59Z","timestamp":1794667619329,"version":"4.9.1"},"reference-count":40,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Open access fees were funded by Wellcome Trust","award":["[Grant number 104079\/Z\/14\/Z]. For the purpose of Open Access, the authors has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission"],"award-info":[{"award-number":["[Grant number 104079\/Z\/14\/Z]. For the purpose of Open Access, the authors has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission"]}],"id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>The objective of this paper is to evaluate available evidence for each step in autoimmune encephalitis management and provide expert opinion when evidence is lacking. The paper approaches autoimmune encephalitis as a broad category rather than focusing on individual antibody syndromes. Core authors from the Autoimmune Encephalitis Alliance Clinicians Network reviewed literature and developed the first draft. Where evidence was lacking or controversial, an electronic survey was distributed to all members to solicit individual responses. Sixty-eight members from 17 countries answered the survey. The most popular bridging therapy was oral prednisone taper chosen by 38% of responders while rituximab was the most popular maintenance therapy chosen by 46%. Most responders considered maintenance immunosuppression after a second relapse in patients with neuronal surface antibodies (70%) or seronegative autoimmune encephalitis (61%) as opposed to those with onconeuronal antibodies (29%). Most responders opted to cancer screening for 4 years in patients with neuronal surface antibodies (49%) or limbic encephalitis (46%) as opposed to non-limbic seronegative autoimmune encephalitis (36%). Detailed survey results are presented in the manuscript and a summary of the diagnostic and therapeutic recommendations is presented at the conclusion.<\/jats:p>","DOI":"10.1136\/jnnp-2020-325302","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T13:20:44Z","timestamp":1614604844000},"page":"897-907","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":150,"title":["Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management"],"prefix":"10.1136","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-8254","authenticated-orcid":false,"given":"Hesham","family":"Abboud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Probasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-9748","authenticated-orcid":false,"given":"Sarosh R","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau","family":"Ances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Pereira","family":"Christo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell C","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireya","family":"Fernandez-Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-2910","authenticated-orcid":false,"given":"Eoin P","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Gadoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Grebenciucova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Jammoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Matiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rae-Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galeno","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Rossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vernino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6140-5584","authenticated-orcid":false,"given":"Sean J","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1033-3840","authenticated-orcid":false,"given":"Maarten","family":"Titulaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"2022033001500933000_92.8.897.1","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/NDT.S82380","article-title":"Autoimmune encephalitis in psychiatric institutions: current perspectives","volume":"12","author":"Bost","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2022033001500933000_92.8.897.2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2000-7976","article-title":"A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia","volume":"33","author":"Schuld","year":"2000","journal-title":"Pharmacopsychiatry"},{"key":"2022033001500933000_92.8.897.3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/dmcn.12882","article-title":"Symptomatic treatment of children with anti-NMDAR encephalitis","volume":"58","author":"Mohammad","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"2022033001500933000_92.8.897.4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou030"},{"key":"2022033001500933000_92.8.897.5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/epi4.12226","article-title":"Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1","volume":"3","author":"Feyissa","year":"2018","journal-title":"Epilepsia Open"},{"key":"2022033001500933000_92.8.897.6","doi-asserted-by":"crossref","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABAb>Bb>R encephalitis","volume":"92","author":"de Bruijn","year":"2019","journal-title":"Neurology"},{"key":"2022033001500933000_92.8.897.7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22307"},{"key":"2022033001500933000_92.8.897.8","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25655","article-title":"Randomized placebo-controlled trial of intravenous immunoglobulin in autoimmune LGI1\/CASPR2 epilepsy","volume":"87","author":"Dubey","year":"2020","journal-title":"Ann Neurol"},{"key":"2022033001500933000_92.8.897.9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx323"},{"key":"2022033001500933000_92.8.897.10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (fires), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"key":"2022033001500933000_92.8.897.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001940"},{"key":"2022033001500933000_92.8.897.12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","article-title":"Autoimmune and paraneoplastic movement disorders: an update","volume":"385","author":"Baizabal-Carvallo","year":"2018","journal-title":"J Neurol Sci"},{"key":"2022033001500933000_92.8.897.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1708712"},{"key":"2022033001500933000_92.8.897.14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.4.479"},{"key":"2022033001500933000_92.8.897.15","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000128110.31784.c8"},{"key":"2022033001500933000_92.8.897.16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318228c136"},{"key":"2022033001500933000_92.8.897.17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.25173","article-title":"N-Methyl-D-Aspartate receptor antibody production from germinal center reactions: therapeutic implications","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann Neurol"},{"key":"2022033001500933000_92.8.897.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0693-7","article-title":"Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis","volume":"7","author":"Chefdeville","year":"2019","journal-title":"Acta Neuropathologica Communications"},{"key":"2022033001500933000_92.8.897.19","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519828601"},{"key":"2022033001500933000_92.8.897.20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx225"},{"key":"2022033001500933000_92.8.897.21","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0013"},{"key":"2022033001500933000_92.8.897.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70310-1"},{"key":"2022033001500933000_92.8.897.23","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.1115720"},{"key":"2022033001500933000_92.8.897.24","doi-asserted-by":"crossref","unstructured":"Shin Y-W , Lee S-T , Park K-I , et al . Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord 2018;11:175628561772234. doi:10.1177\/1756285617722347","DOI":"10.1177\/1756285617722347"},{"key":"2022033001500933000_92.8.897.25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1660819"},{"key":"2022033001500933000_92.8.897.26","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000061"},{"key":"2022033001500933000_92.8.897.27","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"2022033001500933000_92.8.897.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.07.009"},{"key":"2022033001500933000_92.8.897.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70060-7"},{"key":"2022033001500933000_92.8.897.30","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000701","article-title":"Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes","volume":"7","author":"D\u00e9chelotte","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2022033001500933000_92.8.897.31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.24559","article-title":"Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center","volume":"52","author":"Li","year":"2015","journal-title":"Muscle Nerve"},{"key":"2022033001500933000_92.8.897.32","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000268"},{"key":"2022033001500933000_92.8.897.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8627-4"},{"key":"2022033001500933000_92.8.897.34","doi-asserted-by":"crossref","first-page":"e2057","DOI":"10.1212\/WNL.0000000000006577","article-title":"Unintended consequences of Mayo paraneoplastic evaluations","volume":"91","author":"Ebright","year":"2018","journal-title":"Neurology"},{"key":"2022033001500933000_92.8.897.35","doi-asserted-by":"crossref","first-page":"606.1","DOI":"10.1212\/WNL.0000000000008179","article-title":"Reader response: unintended consequences of Mayo paraneoplastic evaluations","volume":"93","author":"Pittock","year":"2019","journal-title":"Neurology"},{"key":"2022033001500933000_92.8.897.36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Ari\u00f1o","year":"2016","journal-title":"Neurology"},{"key":"2022033001500933000_92.8.897.37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002917"},{"key":"2022033001500933000_92.8.897.38","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"2022033001500933000_92.8.897.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03220.x"},{"key":"2022033001500933000_92.8.897.40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cll.2020.05.004","article-title":"Confounders in the interpretation of paraneoplastic and neuronal autoantibody panels","volume":"40","author":"George","year":"2020","journal-title":"Clin Lab Med"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-325302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:55:12Z","timestamp":1648616112000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-325302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,16]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/jnnp-2020-325302"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-325302","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}